Jeremy Weleff
Biography: Dr. Jeremy Weleff, DO is a clinician-researcher and educator in psychiatry at the University of Alberta, with an adjunct appointment at Yale School of Medicine. His work focuses on addiction and substance abuse disorders, psychiatric epidemiology, and social determinants of health. He also collaborates with the Neuroscience and Mental Health Institute on community-engaged research aimed at supporting vulnerable populations.
Prior to joining the University of Alberta, Dr. Weleff completed advanced training in public psychiatry and addiction psychiatry fellowships at Yale-affiliated programs, where he developed expertise in complex clinical care and innovative therapeutic approaches. He has a particular interest in the implementation of strategies for the treatment of stimulant use disorder and concurrent disorders. His lab studies substance use disorders as both biological and systemic phenomena; examining mechanisms, treatment, service design, implementation, and the structural conditions that shape health.
Dr.Weleff is also a key researcher in OASIS (Overcoming and Addressing Stigma In Substance Use Disorders), an ongoing study within the TIME4MH Initiative, that evaluates a community-facing educational intervention designed for clinicians and individuals with lived experience of opioid use, to reduce stigma and barriers to care, and improve treatment engagement and outcomes. He is also a lead on the ANCHOR-MH (Alberta Network for Community Health Outreach and Rural Mental Health) which is a a 12-week training program for family doctors which aims to provide better mental health care for rural and Indigenous patients (https://www.ualberta.ca/en/
Dr. Weleff maintains active involvement in scholarly networks and services as a peer reviewer and research collaborator internationally, reflecting his ongoing commitment to advancing psychiatric science and improving mental health outcomes worldwide.
Node Funded Project (Oct 2025)
Title: Actioning FASD-Informed Care in Substance Use Treatment
Principal Investigators: Jeremy Weleff
Co-investigators/collaborators: Dr Jacqueline Pei, Lucy Digny, Tracey Craig
Description: The current project includes two interconnected activities that aim to improve our understanding of Substance Use Disorder (SUD) in individuals with Fetal Alcohol Spectrum Disorder (FASD) and brainstorm ways to improve the approach to service for this population in addiction treatment settings. For the first part of this project we are conducting a systematic review that aims to synthesize existing literature on the prevalence of SUD among individuals with FASD. The second part of the project is the delivery of a knowledge exchange workshop titled “Actioning FASD-Informed Care in Substance Use Treatment”. This workshop will be co-led by a multidisciplinary team at the Canada FASD conference in October 2025.
